IBDEI1S6 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29812,1,3,0)
 ;;=3^Erectile Dysfunction Following Urethral Surgery
 ;;^UTILITY(U,$J,358.3,29812,1,4,0)
 ;;=4^N52.33
 ;;^UTILITY(U,$J,358.3,29812,2)
 ;;=^5015759
 ;;^UTILITY(U,$J,358.3,29813,0)
 ;;=N52.32^^135^1368^36
 ;;^UTILITY(U,$J,358.3,29813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29813,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Cystectomy
 ;;^UTILITY(U,$J,358.3,29813,1,4,0)
 ;;=4^N52.32
 ;;^UTILITY(U,$J,358.3,29813,2)
 ;;=^5015758
 ;;^UTILITY(U,$J,358.3,29814,0)
 ;;=N52.31^^135^1368^37
 ;;^UTILITY(U,$J,358.3,29814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29814,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Prostatectomy
 ;;^UTILITY(U,$J,358.3,29814,1,4,0)
 ;;=4^N52.31
 ;;^UTILITY(U,$J,358.3,29814,2)
 ;;=^5015757
 ;;^UTILITY(U,$J,358.3,29815,0)
 ;;=N52.2^^135^1368^43
 ;;^UTILITY(U,$J,358.3,29815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29815,1,3,0)
 ;;=3^Erectile Dysfunction,Drug-Induced
 ;;^UTILITY(U,$J,358.3,29815,1,4,0)
 ;;=4^N52.2
 ;;^UTILITY(U,$J,358.3,29815,2)
 ;;=^5015756
 ;;^UTILITY(U,$J,358.3,29816,0)
 ;;=N52.03^^135^1368^34
 ;;^UTILITY(U,$J,358.3,29816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29816,1,3,0)
 ;;=3^Erectile Dysfunction Comb Artrl Insuff & Corporo-Venous Occlusv
 ;;^UTILITY(U,$J,358.3,29816,1,4,0)
 ;;=4^N52.03
 ;;^UTILITY(U,$J,358.3,29816,2)
 ;;=^5015754
 ;;^UTILITY(U,$J,358.3,29817,0)
 ;;=N52.02^^135^1368^35
 ;;^UTILITY(U,$J,358.3,29817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29817,1,3,0)
 ;;=3^Erectile Dysfunction Corporo-Venous Occlusive
 ;;^UTILITY(U,$J,358.3,29817,1,4,0)
 ;;=4^N52.02
 ;;^UTILITY(U,$J,358.3,29817,2)
 ;;=^5015753
 ;;^UTILITY(U,$J,358.3,29818,0)
 ;;=N52.1^^135^1368^42
 ;;^UTILITY(U,$J,358.3,29818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29818,1,3,0)
 ;;=3^Erectile Dysfunction d/t Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,29818,1,4,0)
 ;;=4^N52.1
 ;;^UTILITY(U,$J,358.3,29818,2)
 ;;=^5015755
 ;;^UTILITY(U,$J,358.3,29819,0)
 ;;=N52.01^^135^1368^41
 ;;^UTILITY(U,$J,358.3,29819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29819,1,3,0)
 ;;=3^Erectile Dysfunction d/t Arterial Insufficiency
 ;;^UTILITY(U,$J,358.3,29819,1,4,0)
 ;;=4^N52.01
 ;;^UTILITY(U,$J,358.3,29819,2)
 ;;=^5015752
 ;;^UTILITY(U,$J,358.3,29820,0)
 ;;=N95.2^^135^1368^81
 ;;^UTILITY(U,$J,358.3,29820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29820,1,3,0)
 ;;=3^Postmenopausal Atrophic Vaginitis
 ;;^UTILITY(U,$J,358.3,29820,1,4,0)
 ;;=4^N95.2
 ;;^UTILITY(U,$J,358.3,29820,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,29821,0)
 ;;=R30.9^^135^1368^65
 ;;^UTILITY(U,$J,358.3,29821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29821,1,3,0)
 ;;=3^Micturition Painful,Unspec
 ;;^UTILITY(U,$J,358.3,29821,1,4,0)
 ;;=4^R30.9
 ;;^UTILITY(U,$J,358.3,29821,2)
 ;;=^5019324
 ;;^UTILITY(U,$J,358.3,29822,0)
 ;;=R30.0^^135^1368^26
 ;;^UTILITY(U,$J,358.3,29822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29822,1,3,0)
 ;;=3^Dysuria
 ;;^UTILITY(U,$J,358.3,29822,1,4,0)
 ;;=4^R30.0
 ;;^UTILITY(U,$J,358.3,29822,2)
 ;;=^5019322
 ;;^UTILITY(U,$J,358.3,29823,0)
 ;;=R33.9^^135^1368^105
 ;;^UTILITY(U,$J,358.3,29823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29823,1,3,0)
 ;;=3^Urine Retention,Unspec
 ;;^UTILITY(U,$J,358.3,29823,1,4,0)
 ;;=4^R33.9
 ;;^UTILITY(U,$J,358.3,29823,2)
 ;;=^5019332
 ;;^UTILITY(U,$J,358.3,29824,0)
 ;;=R32.^^135^1368^103
 ;;^UTILITY(U,$J,358.3,29824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29824,1,3,0)
 ;;=3^Urinary Incontinence,Unspec
 ;;^UTILITY(U,$J,358.3,29824,1,4,0)
 ;;=4^R32.
